State Board Of Administration Of Florida Retirement System Cerevel Therapeutics Holdings, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$38.96 - $42.75 $159,346 - $174,847	4,090 Added 29.07%	18,160 $742,000
Q1 2024 May 08, 2024	SELL	$40.88 - $43.27 $167,199 - $176,974	-4,090 Reduced 22.52%	14,070 $594,000
Q4 2023 Feb 09, 2024	BUY	$20.27 - $42.44 $10,135 - $21,220	500 Added 2.83%	18,160 $769,000
Q3 2023 Nov 08, 2023	BUY	$20.26 - $31.91 $1,823 - $2,871	90 Added 0.51%	17,660 $385,000
Q2 2023 Aug 11, 2023	BUY	$23.9 - $35.38 $83,650 - $123,830	3,500 Added 24.88%	17,570 $558,000
Q4 2022 Feb 07, 2023	BUY	$25.35 - $31.96 $9,126 - $11,505	360 Added 2.63%	14,070 $444,000
Q2 2022 Aug 05, 2022	BUY	$20.62 - $37.15 $282,700 - $509,326	13,710 New	13,710 $362,000

Others Institutions Holding CERE

# of Institutions

Shares Held

5.01M

Call Options Held

3.3K

Put Options Held

View Full List

About Cerevel Therapeutics Holdings, Inc.

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

More about CERE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account